CBD Beverages – Possible Next Big Disruptor in the Drinks Industry

CannabisNewsWire Editorial Coverage: Drinks infused with cannabis-derived cannabidiol (CBD) are in a prime position to bring disruption to the beverage sector.

  • The growing consumer interest in hemp-derived CBD as a health supplement along with the recent passing of the Farm Bill has spawned a growing interest in CBD-infused drinks.
  • The ever-increasing global trend to legalizing cannabis is also creating demand for “harder” beverages derived from marijuana
  • Big alcohol companies have taken a particular interest in investing in cannabis producers.
  • The relationship is also working in an inverse direction, with CBD producers recruiting experienced beverage executives to help launch new products.

Corporate interest in building a cannabis-infused beverage profile demonstrates the level of potential growth for such an industry, with key developments being made across multiple channels. To address the needs of the wellness-oriented consumer, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) (PHVAF Profile) has created a line of active hemp extract (CBD)-infused drinks that are just starting to hit store shelves and is expected to be distributed to a thousand retail outlets in Q2. In the adult beverage sector, Constellation Brands Inc. (NYSE: STZ) has made a $4 billion investment in Canopy Growth Corp. (NYSE: CGC) (TSX: WEED), fueling research into cannabis drinks which suggests a proactive approach to addressing the potential sales impact in markets where consumer use of marijuana is legal. The Canadian business unit of Molson Coors Brewing Company (NYSE: TAP) has also made a deal with a cannabis producer to create beverages for that market. In the health supplements sector, Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB), which markets hemp-derived CBD oil, has recruited a former Coca-Cola executive to bring…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – First Specialist Medical Marijuana Clinic Opens in the UK

Last Saturday (March 9) saw history being made in the UK as the first specialist medical cannabis clinic opened in Manchester. The clinic is called The Beeches Consulting Center.

The opening of this clinic has been widely welcomed by patients and clinicians in the UK. This cannabis clinic is owned by European Cannabis Holdings (ECH), a group of companies that plans to open many more such clinics across the UK.

The clinic will be headed by two respected professionals in the medical field. These are an independent pain specialist, Dr. David McDowell, and the second is a consultant neurologist, Professor Mike Barnes.

Dr. McDowell also holds the distinction of being the first specialist to issue a medical cannabis prescription in the UK when the British government enacted a law that made it possible for patients to access medical cannabis starting from December 1. 2018.

Forzana Nazir is one of the first patients that Dr. McDowell issued a medical cannabis prescription to. She is eternally grateful for this because she has been able to transition from taking 13 different medications for her genetic disorder to just three prescription medications ever since she started taking medical marijuana.

Nazir suffers from Ehlers Danlos Syndrome that made her nearly bedridden on a permanent basis due to the severe pain, vomiting and nausea. She credits medical marijuana for significantly improving her quality of life and also for weaning her off many prescription opioids.

The opportunities offered by this new clinic have huge significance given the difficulties that patients have been experiencing if they want to access medical cannabis through the NHS (National Health Service).

Patients are required to establish exceptional clinical circumstances, exhaust all the current treatment options available in the UK, get approval from an NHS Trust Medical Director and then get a medical specialist who is willing to accept liability for their medical cannabis treatment. Only then can a patient receive medical marijuana from the NHS. Any wonder that only four patients have so far accessed the NHS medical marijuana?

The clinic in Manchester, and others that will be opened, will offer an alternative to the complicated bureaucracy associated with getting medical marijuana through the NHS. For now, the clinic will treat chronic pain (due to arthritis, spasticity, fibromyalgia, etc.), psychiatric conditions (anxiety, depression, PTSD, etc.) and neurological conditions, such as Parkinson’s disease, Alzheimer’s, multiple sclerosis and epilepsy.

Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) congratulate ECH upon that major milestone of opening the first specialized medical marijuana clinic in the UK. That is a major investment which should open the eyes of other businesses to the massive opportunities that exist in the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – The US Cannabis Industry Has So Far Created 211,000 Full-Time Jobs

Because marijuana remains illegal at the federal level, it isn’t possible to get accurate statistics about the jobs available in the industry from federal agencies like the Bureau of Labor Statistics. However, Whitney Economics and Leafly.com decided to painstakingly gather the data from each state where cannabis is legal and their findings are eye-catching.

The data analysts discovered that so far, the legal cannabis industry has created 211,000 full-time jobs within the U.S. This shows that the industry is one to watch if the problem of unemployment is to be tackled.

The statistics collected show that out of the 211,000 full-time jobs created so far, 64,000 were filled in 2018 alone. Not bad for an industry that remains illegal at the federal level.

There is no indication that the increase in cannabis jobs is going to slow down any time soon. For example, 2017 saw a 21 percent increase in the number of jobs created in the industry while that number jumped to 44 percent in 2018. 2019 should show a higher rise in the percentage of new jobs created.

You may be wondering how the cannabis workforce increase compares to other sectors/industries. According to the Bureau of Labor Statistics, three industries are likely to have the highest increase in jobs over the coming ten years.

The demand for wind turbine technicians is expected to increase by 96 percent while the demand for solar voltaic installers is likely to increase by 105 percent. The need for home health care aides will rise by 47 percent. All these figures predict workforce increases over at least a decade. However, the data collected by Leafly and Whitney Economics shows that the marijuana industry will achieve a 110 percent increase in jobs created in just over three years!

The figures get even more astounding when they are broken down on a state-by-state basis. For example, Florida saw a 703 percent increase in the cannabis jobs created during 2018. New York ended 2018 with an extra 5,000 full-time jobs in the cannabis industry, marking an increase of 278 percent.

Five states (Oklahoma, California, Arkansas, Massachusetts and Florida) are currently in need of thousands of employees in the cannabis sector, and this demand may keep rising over the coming years as the industry matures. Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) welcome the research done by Leafly and its partners since this data proves that cannabis can bring huge economic benefits wherever it is legalized.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New York Prosecutor Drops Marijuana Charges

A group of 35 people in Erie County received an unexpected gift when John Flynn, the Erie County District Attorney, requested that a judge at the Buffalo City Court accept the prosecutor’s request to dismiss the low-level marijuana charges (misdemeanor charges) against the nearly three dozen people.

The judge agreed with the prosecutor, and the charges were dismissed. It should be noted that the 35 people weren’t present in court. Their warrants were still outstanding and they had missed their court appearances.

In effect, the prosecutor saw no need to continue hunting for those individuals over a substance that would soon be legal throughout the state.

The action taken by John Flynn means that going forward, the District Attorney will no longer be interested in prosecuting such low-level marijuana cases within the jurisdiction.

The Erie County District Attorney isn’t the first to take such action within the state. Flynn is following in the footsteps of the prosecutors in New York City.

The mayor of Buffalo city is also on record for ordering the police in the city to stop arresting people for low-level marijuana crimes, such as possession of small amounts of cannabis.

These actions by prosecutors and the elected leaders seem to acknowledge that while the legislative process to legalize cannabis hasn’t been concluded, the population has gone ahead and started consuming recreational cannabis to such a high degree that it would be hard to clamp down on all of those users.

There is also widespread agreement across the state regarding the need to legalize marijuana for adult-use. Only law enforcement agencies and some members of the medical field still have reservations about adult-use marijuana.

The other disagreements are largely about how the industry will be regulated and where the taxes collected from cannabis will be spent.

For example, sections of lawmakers want the taxes collected from the recreational cannabis sector to be earmarked for revamping the dilapidated infrastructure in the state, such as the aging subway system.

However, others want a large portion of the cannabis taxes to be spent in the impoverished communities that bore the brunt of the war against drugs. The legislators in this school of thought have even threatened to vote against legalization if the law doesn’t stipulate what fraction of the marijuana taxes will go to the underprivileged communities in the inner cities.

What should be applauded in the meantime is the proactive step taken by the prosecutors to stop going after people who commit low-level marijuana infractions as the politicians are hashing out a law to legalize adult-use cannabis. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) are hoping that the lawmakers put the interests of New Yorkers first so that the best law is made for that jurisdiction.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Chronic Pain Tops Reasons for Medical Cannabis Use in America

A new study has found that most Americans use medical marijuana in order to ease chronic pain. The study was aimed at finding out the exact reasons why people in the U.S. use medical marijuana, and whether those stated reasons have any scientific basis.

Kevin Boehnke, a researcher at Michigan University’s Chronic Pain and Fatigue Research Center, led the team of researchers who started by analyzing a report that was written in 2017 on the use of medical marijuana. This report was written by the National Academies of Sciences, Engineering and Medicine.

That 2017 report found either conclusive or substantial proof that cannabis eased nausea, muscle spasms, vomiting and chronic pain.

Boehnke and his team also found that in 2016, the number of people who were registered to use medical cannabis was 641,000. This number rose to 814,000 the following year (2017). However, the researchers believe that the actual number of medical cannabis users exceeds the statistics captured in the report they read.

The statistics show that 85.5 percent of medical cannabis card holders were convinced that there was science backing their desire to use medical cannabis for the different qualifying conditions they suffered from. Chronic pain topped the list of qualifying conditions taking up 62 percent of all applications for medical cannabis cards.

The team of researchers wasn’t surprised by their findings regarding chronic pain given that approximately 100 million Americans are estimated to suffer from chronic pain.

Many of those medical cannabis users, such as Brandian Smith from Illinois, say that they resorted to medical cannabis because it worked better than the prescription opiates that they had been using previously.

This anecdotal evidence from actual medical cannabis users, together with the scientific studies that prove that medical marijuana can combat chronic pain, may offer a ray of hope in the fight against the opioid crisis in the U.S.

Currently, 33 states have legalized the use of medical marijuana. 10 states, as well as the District of Columbia, have decriminalized adult-use marijuana. These 33 states can potentially start a wave rolling back the opioid problem if this matter is given more attention.

For now, the federal government remains adamant that marijuana hasn’t been proved to have any medical use, so it remains a Schedule 1 substance. Boehnke and his team of researchers feel strongly that their findings make a case for changing the federal government’s position so that cannabis can be integrated in the medical system of the country. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) couldn’t agree more with Kevin Boehnke’s conclusions.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – UC Berkley Launches Cannabis Research Center

The University of California at Berkley has announced that it has opened a cannabis research center that will study the effects of cannabis production upon society and the environment. This announcement was made on Tuesday this week (January 29).

UC officials also revealed that the research center will primarily focus on three major areas.

The first is cannabis regulation and policy. Cannabis regulations and policies have been evolving rapidly and they merit research in order to ascertain whether those policies and regulations have made the industry better, whether the policymakers had sufficient information upon which they based when drafting the regulations and policies, etc.

The research center will also study how cannabis production affects the environment. For example, what effects do cannabis plants have on groundwater? Is it better (for the environment) to grow cannabis in indoor facilities or outdoor grows are better? How can the adverse environmental impacts (if any) of cannabis production be mitigated? Such, and other issues will occupy the researchers who will devote their time and resources to looking into the environmental effects of cannabis production.

The third major area of research will be the impact of cannabis production on society. Already, some lawsuits have been filed against cannabis grow facilities in some neighborhoods while some local authorities have enacted ordinances that ban any marijuana-related activities in their jurisdictions. At the same time, many communities are clamoring to have cannabis production facilities in their areas in order to reap the economic benefits that such developments bring. So, the responses to cannabis production span the entire gamut of what anyone can imagine as a potential reaction to this controversial plant. The researchers will look into all these societal effects and provide scientific data to inform the decision-making process.

Ted Grantham and Van Butsic, both faculty members in UC Berkley’s Department of Policy and Management, and Environmental Sciences will head the interdisciplinary team at the research center.

The direction taken by the research center at UC Berkley is unique because so far, other researchers have devoted their resources to studying how cannabis affects people (the positive and negative) at the level of an individual. Grantham and his team want to broaden the lens and look at the bigger picture. This approach is a welcome development for the cannabis industry, including Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), because it will provide deeper insights into the broader aspects of the industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – What to Expect When Entering an Ohio Medical Marijuana Dispensary

The first medical marijuana dispensaries in Ohio opened on Wednesday, January 17 and many patients who were entering a dispensary for the first time didn’t know what to expect. Several operators of dispensaries shared their thoughts on how Ohio patients can make their visit to a dispensary seamless. This article discusses some of their suggestions.

Patients and Caregivers Only

The first thing that people who want to buy medical cannabis should know is that only patients and their caregivers will be allowed into a dispensary. Families are therefore advised to refrain from accompanying a patient to the dispensary since they will not be allowed to access the premises if they aren’t cardholders or caregivers.

Prepare In Advance

Patients and their caregivers are also advised to prepare adequately before heading out to a medical cannabis dispensary. This preparation includes confirming that one completed the registration process as well as setting aside cash for their purchase since dispensaries will not be accepting credit cards or health insurance. It is also prudent to carry the same photo ID that you used when enrolling for the program.

Don’t Touch

Medical cannabis dispensaries in Ohio will have a room in which patients and their caregivers can view the different products available. However, no one will be allowed to touch any product on display unless a dispensary employee permits them to. You can only see or smell the products.

No Onsite Consumption

Once a patient or their caregiver has selected what they will purchase, the products will be cleared at the check-out counter and you can leave the dispensary. No one is allowed to consume medical marijuana within the dispensary premises or anywhere in public. Ohio law stipulates that medical marijuana can only be consumed in the privacy of one’s home.

Check Dispensary Locations

So far, there are 56 medical marijuana dispensaries licensed by Ohio State. However, not all of them will be in position to open immediately, so patients are advised to check online and confirm that the dispensary they wish to buy products from will be open on the day one needs to visit the facility. For example, just 4 out of the 56 licensed dispensaries opened on Wednesday.

The medical marijuana dispensaries have indicated that they will give each patient as much time and information as possible in order to help them to select the best products for their needs. This promise is a welcome gesture because not many patients will be certain about what to buy for their conditions. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Net Element (NASDAQ: NETE) congratulate Ohio upon kick starting their medical cannabis program.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Three Medical Marijuana Issues That Iowa May Need to Revisit

Iowa legalized medical cannabis in 2014, but the rate at which the state has adapted to the changing realities of the industry is so slow that many have been left frustrated by how oblivious the state legislature is to the things that laypeople see every day. Of specific concern are the three issues below.

The Number of Licensed Dispensaries

The entire state of Iowa has only five medical cannabis dispensaries from which patients can legally acquire what they need for their health challenges. For example, Cedar Rapids doesn’t have any licensed dispensary within its borders and yet this is the second largest city in the state. How is it possible that no dispensary is located there and yet there is no local bylaw banning cannabis businesses from operating there?

This just goes to show that the authorities didn’t consider the demand for medical cannabis when passing the law that restricted the number of licensed dispensaries to just five. What they may not know is that such a limit can unwittingly encourage the black market to thrive in the state since the illicit supply can easily reach every corner of the state.

The Cap on THC Levels

The regulations in place limit how much THC medical cannabis can contain to 3 percent. THC is the cannabinoid that makes people “high”. The board overseeing the medical cannabis program voted unanimously to retain the 3 percent limit on THC for another year or two before revisiting the matter.

While it may be reasonable to set a limit on how much THC people consume when they buy medical cannabis, such a limit should not be so low that patients will be compelled to consume a larger quantity of cannabis in order to get the desired effects.

It would be better for the authorities to provide a rationale for that 3 percent THC limit and get feedback from experts and the public on the same before enacting it into law. As things stand, patients may be compelled to spend more money buying a larger quantity of cannabis since there is no cap on the quantity they can buy.

The Qualifying Conditions

Iowa is operating as though it is the first state to legalize medical cannabis and yet there are several precedents to learn from. California is reputed to have some of the strictest regulatory controls not just for medical cannabis but for everything else. However, California created a list of dozens of conditions for which medical cannabis could be bought long before recreational cannabis was legalized.

Iowa started by allowing medical cannabis for only epilepsy, then eased up a bit in 2017 to include a few more conditions. What is baffling is that post-traumatic stress disorder (PTSD), ADHD and bi-polar weren’t added to the list and yet nearly all other states include them among the qualifying conditions.

All in all, the board in charge of the medical marijuana program needs to be more foresighted and stop being reactive in its approach. Otherwise, the program will not attain its intended objectives. No one, including Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Net Element (NASDAQ: NETE), would want this beneficial program to fail.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Legalization Has Reduced Smuggling and Improved Border Security, Study Finds

A new study has shown that the legalization of marijuana in different states has reduced drug smuggling and made the Southern U.S. border safer. This research was conducted by the Cato Institute.

The Cato Institute analyzed data on how much marijuana has been seized by Border Patrol agents over time. Customs and Border Protection (CBP) regularly releases statistics about the different drugs that have been seized at the different ports of entry into the country.

The analysis shows that over a period of five years, the quantity of marijuana smuggled has reduced by a whopping 78 percent. Similarly, the amount of marijuana seized by each Border Patrol agent has reduced by an average of 70 percent.

Colorado and Washington were the pioneers of marijuana legalization, and there are nearly a dozen states that have now ended the prohibition of marijuana. Many more are set to follow suit in the coming years as ballot measures and legislative action is already in advanced stages in several states as this year ends.

The Cato analysis is timely since it comes at a time when the White House is pushing hard for the construction of a wall on a large section of the border with Mexico. In fact, disagreement over the border wall even caused a partial government shutdown that is still ongoing.

The analysis of smuggling data shows that building a wall at the Mexican border isn’t likely to reduce the rate (and quantity) of the drugs smuggled into the U.S. Remember, the number of Border Patrol agents was dramatically increased between 2003 and 2009, but the CBP seizures data didn’t show any decline in the per-agent marijuana seizures. Only legalization has resulted in such a reduction since most consumers are more comfortable buying their cannabis from regulated sources instead of taking a chance with the smuggled substance for which no quality controls are implemented.

It is also worth remembering that the U.S. government constructed hundreds of miles of border fencing at about the same time when it doubled the CBP workforce, but there was no change in the data on smuggling. It may therefore be reasonable to expect that the wall may not fare any better since the real reason for smuggling (the lack of legal marijuana in some states) hasn’t been addressed.

As for the different marijuana industry players like Plus Products Inc. (CSE: PLUS) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), the Cato research is yet another piece of evidence that marijuana legalization has so many direct and indirect benefits.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Medical Marijuana May Soon Be Allowed in Federally Subsidized Housing

The New York and New Jersey regional officer of the Department of Housing and Urban Development (HUD), Lynne Patton, has revealed that there is a need to reconcile state and federal marijuana laws so that individuals who are using medical marijuana in locations where it is legal don’t risk losing federally subsidized housing.

She was reacting to media reports about a 78-year old man (John Flickner) who had been evicted from his apartment in Niagara Falls, New York due to his use of medical cannabis.

Lynne Patton went on to reveal that she was working to get Flickner back into permanent housing once more, as well as helping any other individuals in the same situation.

The good news is that John Flickner received a call from his former landlord asking him to retake his apartment shortly after Flickner’s case appeared in the media. The company owning that block of apartments also revealed that it was reconsidering its policy on medical marijuana. It was not clear whether the Department of Housing and Urban Development played a role in getting Flickner to return to his old apartment.

New York is expanding its medical cannabis program, and plans are underway to legalize recreational marijuana as well. These developments have raised concerns about what will happen to all those people who live in federally subsidized housing and want to use medical or recreational marijuana.

It should be remembered that President Clinton signed a law in 1998 barring landlords from having a tenant (new or existing) who uses an illegal substance, such as cannabis.

However, President Obama’s government wrote a memo in 2014 clarifying that landlords had the liberty to accept or reject (even evict) tenants who consume illegal substances. The eviction of Flickner was therefore done at the discretion of the landlord since there was no legal obligation for that action to be taken.

Good news may be on the way for people in federal housing regarding marijuana. This is because the Department of Housing and Urban Development (as hinted upon by Patton) is working to clear up the policy issues resulting from the difference between state and federal laws. In the meantime, Congress may act on the same issue either sooner or after HUD reconsiders its position formally.

Congresswoman Eleanor Holmes Norton, a Democrat from DC, introduced a bill that seeks to provide housing safeguards at the federal level for people using either medical or recreational marijuana in legal states.

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), Plus Products Inc. (CSE: PLUS) and others in the industry are saddened by the fact that an old man (John Flickner) had to undergo the distress of being evicted in order for the housing authorities to see that things need to change.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com